Gene: FJX1
Official Full Name: four-jointed box kinase 1provided by HGNC
Gene Summary: The protein encoded by this gene is the human ortholog of mouse and Drosophila four-jointed gene product. The Drosophila protein is important for growth and differentiation of legs and wings, and for proper development of the eyes. The exact function of this gene in humans is not known. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO28944 | FJX1 Knockout cell line (HeLa) | Human | FJX1 | 1:3~1:6 | Negative | Online Inquiry |
KO28945 | FJX1 Knockout cell line (HCT 116) | Human | FJX1 | 1:2~1:4 | Negative | Online Inquiry |
KO28946 | FJX1 Knockout cell line (HEK293) | Human | FJX1 | 1:3~1:6 | Negative | Online Inquiry |
KO28947 | FJX1 Knockout cell line (A549) | Human | FJX1 | 1:3~1:4 | Negative | Online Inquiry |
FJX1 Gene Knockout Cell Lines are genetically modified cell lines designed to specifically lack the expression of the FJX1 gene. This innovative biotechnology product allows researchers to explore the biological role of the FJX1 gene, which has been implicated in cellular processes such as apoptosis and cellular proliferation. By knocking out this gene, scientists can gain critical insights into its function and its contributions to various physiological and pathological states.
The primary mechanism of action involves the use of CRISPR-Cas9 technology for precise gene editing, leading to a complete knockout of the FJX1 gene. This advanced approach enables the generation of stable cell lines that facilitate the study of gene function in vitro. Researchers can utilize these cell lines for a wide range of applications, including drug discovery, functional genomics, and the study of disease mechanisms, effectively bridging the gap between in vitro research and clinical applications.
The scientific importance of FJX1 Gene Knockout Cell Lines is evident in their potential to advance knowledge in fields such as cancer research and regenerative medicine. By elucidating the role of FJX1 in disease processes, these cell lines contribute valuable information that can enhance therapeutic strategies and foster the development of novel interventions.
What sets FJX1 Gene Knockout Cell Lines apart from alternative products is their high specificity and reliability. Unlike traditional knockout methods, the CRISPR technology ensures a targeted approach, minimizing off-target effects and increasing the validity of experimental outcomes. Furthermore, these cell lines come with extensive characterization data, providing users with the confidence needed for robust experimental design.
For researchers, clinicians, and biotechnology companies, the ability to study the implications of the FJX1 gene through these knockout cell lines offers a significant advantage in the quest for precision medicine. The insights gained from using this product can lead to breakthroughs in understanding complex biological systems and diseases.
Our company prides itself on its expertise in developing cutting-edge scientific tools supported by rigorous research and quality assurance. The FJX1 Gene Knockout Cell Lines exemplify our commitment to empowering researchers with innovative solutions that drive scientific progress.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.